Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
APOLO Biotech Developing RNA's technologies Development of RNA-based technologies to enhance the productivity of crops (mainly intensive) which are respectful towards the environment and human health. Our OGM-free technology allows us to immunize crops against specific pathogens (fungi, insects, viruses), as a sort of "vaccine". In addition, we know how to modulate crop development, its response to the environment or the accumulation of metabolites of interest by designing RNAs as exogenous bioactive molecules to modulate the activity of plant genes. Fruits, Biotech, RNA, ARN, Plants, Vegetables, and Crops Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 30 | |
BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … Type: Startup Activities: biotech deeptech it services Technologies: A.I. Synthetic Biology SaaS Generative A.I. | 19 | 0 | 19 | 107 | |
Paige Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn … Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning A.I. - Deep Learning Generative A.I. | 10 | 1 | 6 | 98 | |
MDClone Unlock healthcare data. Transform care. See #syntheticdata in action. See an ADAMS Platform demo today: Link in bio MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access, and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Unlike traditional analytics platforms, the MDClone ADAMS Platform introduces a fundamentally different approach to healthcare data analysis, exploration, and … Type: Startup Activities: biotech deeptech it services Technologies: Data Analytics A.I. A.I. - Natural Language Processing A.I. - Machine Learning A.I. - Deep Learning Generative A.I. SaaS | 2 | 0 | 1 | 128 | |
Enveda Biosciences Engineering New Drugs from Nature At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. | 4 | 0 | 4 | 248 | |
Generate:Biomedicines Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. Generative A.I. | 13 | 0 | 12 | 319 | |
Ranomics Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
Theranica A new era in migraine therapy Theranica is a neuromodulation therapeutics company dedicated to creating effective, safe, affordable, and low-side-effect therapies for idiopathic pain conditions. Our initial focus is on migraine, one of the most common neurologic disorders affecting over 1 billion people, with a high prevalence and morbidity, especially among adolescents and females. The company’s award-winning flagship Nerivio® REN wearable is changing the game for migraine sufferers, especially the 100 million adolescents facing this complex and non-curable disease. Nerivio is the first and only REN wearable that harnesses the natural power of the brain to shut off migraine symptoms … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 3 | 0 | 2 | 72 | |
Ikan Biotech We are a biotech company, specialized in cancer research. Our technology allows us the development of avatars of cancer patients , using zebrafish. | 1 | 0 | 0 | N/A | |
TolerogenixX GmbH The Smart Way to Immune Tolerance TolerogenixX vision is to innovate Immunosuppression with its newly developed MIC Cell Treatments. MIC Cell Treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Transplant - and Autoimmune Disease Patients. TolerogenixX has been able to generate strong pre-clinical as well as clinical data in the indications of Transplantation and Autoimmune Diseases e.g. SLE since its foundation in 2016. Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
Apoha Currently in stealth - we will reveal soon! Our team of scientists and product experts are on a mission: developing Sensory Intelligence to seamlessly anchor machines into physical reality. Exciting things are in the pipeline... Stay tuned! #SensoryIntelligence #FutureOfMachines | 2 | 0 | 1 | 21 | |
NeuroID, a part of Experian Next-Gen Behavior & Device: Detect Fraud Anywhere User Interaction Occurs NeuroID is now proudly a part of Experian! NeuroID combines the power of industry-leading behavioral analytics with advanced device and network intelligence to create your first line of defense against malicious bots, bad actors, and fraud rings. Secure your entire user lifecycle with a single integration, stopping everything from ID theft to ATO fraud from the very first interaction. Real-Time Behavioral Analytics, Digital Body Language, Advanced Machine Learning, Neuroscience, FinTech, Fraud, InsurTech, Digital Customer, Behavioral Data, Human-Computer Interaction, Data Science, New Account Opening, Verification, Customer Journey, Digital Forms, Behavioral Analytics, … Type: Startup Activities: biotech deeptech fintech insurtech Technologies: A.I. - Machine Learning Data Analytics | 2 | 0 | 2 | 58 | |
LifeOmic Powering Precision Health LifeOmic, a healthcare technology company, works with health care providers, researchers, and health-focused enterprises to aggregate and utilize health data to improve patient outcomes and provide valuable, actionable insights. The LifeOmic Platform goes far beyond storage. Our secure, cloud-based platform forms the technology backbone for aggregating and managing complex health data in oncology, cardiology, MedTech, Pharma and more. The user-friendly interface, configurable mobile app, real-time analysis and visualization and attribute-based access controls meet the needs of each individual or organization. With the LifeOmic Platform you can: - Easily Collect & Analyze Data to Enable the Best Treatment … Type: Startup Activities: healthtech it services biotech deeptech Technologies: A.I. A.I. - Machine Learning SaaS | 5 | 1 | 2 | 19 | |
Stemcentrx, Inc. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates. Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
Basepaws Basepaws is a pet genetics company that creates affordable, easy-to-use health tests for every pet parent. Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. Basepaws is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA. On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws. The acquisition was first announced on June 7th, and the financial terms of the transaction were … Type: Startup Activities: biotech pettech deeptech Technologies: Data Analytics | 8 | 2 | 7 | 37 | |
Halo Join a community of scientific experts working together to bring new innovations to the world Halo is a partnering platform that helps corporate R&D teams discover new technologies, build relationships with the researchers and startups behind them, and more efficiently scale external partnerships globally through the power of networks and AI. Since launching in January 2020, more than 7,000 universities from 135+ countries have joined the platform. In 2021, Halo was recognized as one of Fast Company's 2021 World Changing Ideas. On Halo, corporate R&D divisions post areas of interest for research collaborations (ie. Request-For-Proposals) and interested parties (scientists, startups, … Type: Startup Activities: biotech deeptech fintech Technologies: Synthetic Biology | 11 | 1 | 10 | 162 | |
Veritas Genetics Veritas Genetics is now a LetsGetChecked company. For future updates on the combined entity, follow @LetsGetChecked. Clinical Diagnostics, Genetics, Whole Genome Sequencing, and Genomics | 3 | 0 | 3 | 33 | |
Aratana Therapeutics Inc. Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets … Type: Startup Activities: deeptech pettech biotech manufacturing Technologies: Synthetic Biology | 2 | 0 | 0 | 16 | |
BrainCheck Digital cognitive care – anytime, anywhere BrainCheck is a digital health company powering positive progress in cognitive health. The BrainCheck PlatformTM offers the most comprehensive digital cognitive toolset to promote proactive screening, detect early signs of decline, and personalize care planning – anytime, anywhere. Founded by renowned neuroscientists and technologists, including David Eagleman, PhD, our intuitive solutions transcend the limitations of traditional methods and expand access to cognitive care with the tap of a finger, from any device, in any location. Trusted by hundreds of leading providers and healthcare systems, our clinically-validated digital cognitive assessment and care planning tools fit … Type: Startup Activities: healthtech biotech deeptech Technologies: Affective Computing Data Analytics | 5 | 1 | 5 | 83 | |
Neurable Your mind. Unlocked. 🧠 The Mind. Unlocked. Work Smarter. Live Better. Through proprietary brain-computer interface (BCI) technology, Neurable is pioneering the future of human-computer interaction by allowing you to use the power of your brain to get more out of your everyday devices. Brain-Computer Interface, Machine Learning, Virtual Reality, Augmented Reality, and Neuroscience Type: Startup Activities: deeptech biotech Technologies: VR Affective Computing A.I. A.I. - Machine Learning | 9 | 3 | 4 | 41 | |
Biofourmis Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science … Type: Startup Activities: deeptech healthtech biotech Technologies: A.I. Data Analytics | 34 | 3 | 31 | 393 | |
OmicsLogic Inc. Deciphering Omics Data with Precision and Pioneering Data Science to Unveil the Language of Life. Deciphering Omics Data with Precision and Pioneering Data Science to Unveil the Language of Life. Unleash the power of data with our advanced analysis pipelines, designed to let you navigate omics data with ease and precision. Our specialists are here to guide you every step of the way, ensuring a seamless transition from learning to application. We facilitate your entire research journey, providing custom-built tools and software solutions tailored to meet your specific research needs. Biotechnology, Bio medicine, Personalized Medicine, Computational Analysis, STEM Education, Bioinformatics, … Type: Startup Activities: deeptech biotech edtech Technologies: Data Analytics | 5 | 0 | 5 | 22 | |
The Brave Like Gabe Foundation The Brave Like Gabe Foundation supports cancer research and empowers all cancer survivors through physical activity. "Brave Like Gabe” started as a hashtag to support professional runner Gabriele “Gabe” Grunewald as she sought treatment for her third battle with an incurable rare salivary gland cancer in 2017. As a professional runner and rare cancer advocate, Gabe founded The Brave Like Gabe Foundation to share her story, inspire others to connect and do the same, and to make a difference in the cancer community. During her cancer journey, Gabe experienced firsthand many of the challenges faced by rare cancer patients and … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 1 | 1 | 0 | 7 | |
LithuaniaBIO Uniting Lithuanian life science&biotechnology sector stakeholders: companies, universities, scientists, professionals. LithuaniaBIO is a legal entity established in 2003 on the basis of Lithuanian Society of Biotechnologists. Currently association unites companies developing and producing biotechnological products, providing services for life science sector, also Lithuanian universities and individual researchers actively participating in fundamental and applied science. LithuaniaBIO goal is to facilitate Lithuanian biotechnology sector to solve global life quality and environmental challenges. Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 4 | 0 | 3 | 12 | |
Our Future Health UK The UK's largest ever health research programme Our Future Health is the UK’s largest ever health research programme, bringing people together to develop new ways to prevent, detect and treat diseases. Our mission is to create an incredibly detailed picture of the UK population’s health, by recruiting up to five million adult volunteers from across the UK. Each volunteer will be asked to fill out a questionnaire and provide a blood sample that can be linked to their health records. Taken together, the data will present health researchers with a powerful tool to identify new ways of tackling diseases such … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech healthtech | 10 | 1 | 9 | 293 | |
Greiner Bio-One International making a difference Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One has specialised in two business division, Preanalytics and BioScience. The Preanalytics business division, with headquarters in Kremsmünster (Austria), develops and produces innovative collection systems for human and veterinary blood, urine and saliva samples, with the aim of making day-to-day, routine tasks in hospitals, laboratories and doctors’ practices easier and safer. This division also covers customised software solutions (Greiner eHealth Technologies) which ensure … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 2 | 0 | 0 | 542 | |
Certest Biotec, S.L. Products and solutions for Raw Materials, Diagnostics and Pharma. MORE THAN DIAGNOSTICS! Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 216 | |
Biomedal Bioinnovation at your service. Biomedal S.L is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. The company develops its activities in two areas: Biomedal Life Sciences and Biomedal Diagnostics. Biomedal Life Science is devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Its own technology allowed the improvement of recombinant protein production.Biomedal Life Science also functions as a CRO (Contract Research Organization) and provides services and support to pharmaceutical or biotechnology companies. Biomedal Diagnostics offers a large variety … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 29 | |
Ingenza Ltd ADVANCED BY NATURE. ADVANCED BY NATURE® Ingenza is a dynamic CRDMO whose understanding of nature and unique engineering biology toolbox, accelerate the customer journey through key milestones to commercial success. We engineer biological systems to make everything from therapeutics to enzymes and consumer products, addressing challenges in human health and the global environment. Enzyme Discovery, Enzyme Evolution, Molecular Biology, Protein Synthesis, High Throughput Screening, Strain Engineering, Fermentation, Process Development, and Synthetic Chemistry Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 3 | 45 | |
Hunter International Recruiting Connecting Top Talent With Innovative Corporations Nationwide. Hunter International Recruiting is a premier staffing and recruiting firm specializing in sourcing top talent in engineering, IT, finance, accounting, and scientific roles. We deliver service-based solutions to a wide array of clients, including Fortune 1000 companies, with a strong presence across the U.S. In addition to staffing services, Hunter International offers culture consulting and a variety of client programs through our professional services division. Our commitment to excellence and deep industry expertise ensure we consistently deliver the highest quality candidates and comprehensive workforce solutions. To learn more, visit www.hirecruiting.com Recruiting, Engineer, Staffing, … Type: SMB Activities: hrtech biotech deeptech fintech transporttech Technologies: Data Analytics | 7 | 0 | 7 | 105 | |
BPGbio, Inc. #AI #biopharma #therapeutics #mitochondrial #proteinhomeostasis #oncology #neurology #raredisease #drugdiscovery BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be … Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology | 11 | 2 | 7 | 71 | |
WCG Metrics Champion Consortium A WCG Clinical Services Company Driving improvement through collaborative use of standardized metrics. The MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers, and sites to improve clinical trial development through use of MCC standardized performance metrics (time, cost & quality). • Develop standardized performance metrics and tools • Support metrics and tools implementation • Share best practices among MCC members • Provide metrics and tools training • Provide performance benchmarking using member data • Produce publications to increase member knowledge The MCC is made up of industry volunteer working groups to develop and implement metrics and … Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 0 | 0 | 0 | 3 | |
Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 8 | 2 | 3 | 717 | |
Dominique Dutscher A culture of service, quality, responsiveness and customisation... Founded in 1982 by M. Dominique Dutscher, our company, based in Alsace,has from the ouset specialized in the distribution of consumables and laboratory equipment for research, biotechnologies and health. Dominique Dutscher SAS has rapidly developed into expanding its catalog, multiplying its services, expanding distribution agreements with new manufacturers that have given it their confidence, by broadcasting new products on the market, paying particuliar attention to the quality of its service to its customers and to the respect of its commitments. Matériel de laboratoire, Consommables, Equipement de laboratoire, Biotechnologies, Industrie, Agroalimentaire, and Salles … | 11 | 2 | 5 | 178 | |
Genomic Vision Genomic Vision is a French biotech providing tools and services to visualize and characterize single DNA molecules. GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. GENOMIC VISION initial focus is towards early cancer detection and … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 0 | 19 | |
Advamedica Inc. Biomaterials. Hemostats. Medtech Advamedica Inc. is a deep science medtech company focused on biomaterial based medical devices. Hemostats, Woundcare, and Biomaterials Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Cocoon Biotech Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 6 | |
Outcomes® Outcomes® unites technology and clinical relationships through a connected healthcare network to drive better outcomes. As a leading patient-centric technology business, we unite pharmacies, payers, and pharmaceutical companies through patient engagement solutions, tailored tools for the future pharmacy, and advanced workflow optimization. Our comprehensive offerings benefit a nationwide network of 48,000 community, chain, and grocery pharmacies, and more than 70 million patients. Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics SaaS | 0 | 0 | 0 | 765 | |
Biosortia, Inc. Unlocking the Hidden Chemistry of Microbiomes for Next-Generation Therapeutics with ISMM + HiMo-silco Generative AI Biosortia Pharmaceuticals is pioneering a revolutionary approach in drug discovery through its Industrial Scale Microbiome Mining (ISMM) technology. By accessing the vast, untapped chemical diversity found within natural microbiomes, We unlock a hidden world of small molecules that play crucial roles in cellular signaling and disease processes. These small molecules, often referred to as the "drug-like dark matter" of cellular biology, have been largely inaccessible until now. Our technology allows for the large-scale harvesting and exploration of these compounds, providing an unprecedented opportunity to discover … Type: Startup Activities: deeptech biotech Technologies: A.I. - Machine Learning A.I. Data Analytics Synthetic Biology | 1 | 0 | 1 | 10 | |
Syros Pharmaceuticals By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome with RARA gene overexpression. For more information, visit www.syros.com and follow us on X (@SyrosPharma) and LinkedIn. | 7 | 2 | 4 | 89 | |
Kernal Biologics KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space. synthetic biology, RNA design, immunotherapy, covid-19, cancer, and mRNA therapy Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 2 | 4 | 16 | |
Poolbeg Pharma plc Committed to the development and commercialisation of innovative medicines. Ticker: POLB Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to fund the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I. | 6 | 0 | 6 | 15 | |
Pharvaris Pioneering science for patient choice Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 113 | |
OneChain Immunotherapeutics Development of CAR-T candidates for the treatment of acute lymphoblastic leukemia and other hematological malignancies. OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez. Biomedicina, CARTs, Inmunoterapia, Investigación, Biotecnología, Innovación, Leucemia, Hematología, and Medicina Personalizada | 1 | 0 | 1 | 16 | |
Mainz Biomed Saving lives through innovative molecular diagnostic solutions. Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the early onset of several leading deadly conditions including colorectal and pancreatic cancers. Visit our website www.mainzbiomed.com to learn more about our company and our mission to save lives through science. molecular genetic in-vitro diagnostics | 1 | 0 | 1 | 56 | |
Tagworks Pharmaceuticals Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapies Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing protein found on the surface of many solid tumor cells. We are developing a pipeline of novel cancer treatments leveraging our Click-to-Release technology in a range of therapeutic modalities, including ADCs and targeted … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 28 | |
Glentham Life Sciences Ltd. The Chemical, Biochemical & Research Essentials Supplier. Glentham Life Sciences is a UK-headquartered supplier of fine chemicals, biochemicals and raw materials. We are focussed on delivering high quality, well-documented products for the Diagnostics, Pharmaceutical, Research and Custom Synthesis markets. Customer service is important to us. Unlike many of our competitors, we offer complete flexibility on packaging units and materials, scheduled deliveries and call-off orders, and delivery of stock products to most of Europe within 24 hours of receiving your order. Our key product ranges include Antibiotics, Amino Acids and derivatives, Carbohydrates and derivatives, Buffers and many more. Glentham Life Sciences … Type: Startup Activities: deeptech biotech Technologies: New Materials | 0 | 0 | 0 | 13 | |
Dicot Pharma AB Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical Type: Startup Activities: deeptech biotech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
biosimulytics AI-powered molecular modelling for accelerated and smarter drug development biosimulytics is a deep-tech spin-out from University College Dublin’s School of Chemical & Bioprocess Engineering, founded in 2019. We specialize in leveraging cutting-edge AI, advanced neural networks , molecular modeling, quantum technologies, and high-performance computing to accelerate the creation of new and improved therapies What We Do: 🔍 Polymorphism Prediction: Tackling pharma’s major challenge by predicting API molecule arrangements. 🧪Structure-Based Drug Design (SBDD): Enhancing drug design with stable binding pose predictions. 🌍Proud EIC Accelerator participants since September 2023, EIT Innovation Team Award finalists, and now an EIT Digital portfolio company after … Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning | 1 | 1 | 1 | 6 | |
Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 13 | 0 | 13 | 40 | |
Berlin Heals Holding AG Cardiac Microcurrent C-MIC - A novel therapy for chronic heart failure Berlin Heals is a Start-up-Company in Berlin, Germany. We are devoted to the treatment of heart failure. We will redefine heart failure treatment with a novel device that is capable of healing the heart. Contact us at info@berlinheals.de to get in touch with us. Get more Information here: www.berlinheals.de R+D and Marketing of a novel cardiovascular device Type: Startup Activities: deeptech healthtech biotech | 0 | 0 | 0 | 26 | |
ARTBIO Empowering patient-centric advances in cancer care ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies. Type: Startup Activities: deeptech biotech healthtech manufacturing | 0 | 0 | 0 | 59 | |
Atomic AI Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people. We're hiring! https://boards.greenhouse.io/atomai Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology Generative A.I. | 2 | 0 | 1 | 34 | |
Evozyne Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. Type: Startup Activities: deeptech biotech Technologies: A.I. - Deep Learning Generative A.I. A.I. | 1 | 0 | 1 | 60 | |
JURA Bio, Inc. Building the future of cell-based therapies. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and Machine Learning Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology SaaS A.I. Generative A.I. | 0 | 0 | 0 | 18 | |
Redesign Science Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases. Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Deep Learning Generative A.I. | 0 | 0 | 0 | 11 | |
A-Alpha Bio The protein-protein interaction company A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. | 5 | 0 | 5 | 59 | |
PictorLabs Inc Histopathology reimagined. PictorLabs, Inc. is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence, and health-tech product development, the Company is reimagining existing histopathology workflows, accelerating clinical and diagnostic results, and improving process sustainability. From a single unstained tissue sample, PictorLabs’ proprietary platform can produce an unlimited number of virtual stains that are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and is creating specialized virtual biomarker … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Image Processing Generative A.I. | 0 | 0 | 0 | 27 | |
Basecamp Research Beyond Known Biology Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraphTM, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology SaaS A.I. | 12 | 1 | 10 | 36 | |
Ordaos Bio Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving treatments. Ordaōs is a human-enabled, machine-driven drug design company. Our miniPROTM proteins help drug hunters deliver treatments that are safer and more effective than traditional discovery methods. Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 1 | 0 | 1 | 29 | |
Atomica AI Next-generation digital dentistry solutions using the power of AI Atomica is a US-based startup that helps doctors provide the best patient care possible using the power of AI, Robotics, and 3D Printing. With groundbreaking technology at the core, Atomica is ushering in a new era of patient care - that is more personalized, precise, and affordable. We are actively building a world-class team. Digital Dentistry, Medical Imaging, AI, Computer vision, AI Startup, Robotics, Medical Robotics, medical device, implants, dentistry, dental implants, rendering, graphics, startup, and geometry Type: Startup Activities: healthtech biotech Technologies: A.I. Robotics 3D Printing A.I. - Image Processing Generative A.I. | 0 | 0 | 0 | 58 | |
Profluent Decoding the language of life with AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Berkeley, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio. artificial intelligence, machine learning, biotech, and gene editing Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning Generative A.I. | 1 | 0 | 1 | 38 | |
Syntegra Democratizing healthcare data to dramatically accelerate how treatments reach patients. Syntegra is unlocking the promise of real-world evidence by employing a groundbreaking machine learning model — the Syntegra Medical Mind — to enable low-burden access to privacy-preserved and equitable synthetic health data, increasing the value of data for those who have it and providing access for those who need it. Synthetic data matches the statistical accuracy of the underlying data without linking to any actual patients, fully protecting patient privacy. Syntegra’s ever-growing model is built from the statistical patterns of structured healthcare data to serve the diverse needs of our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics A.I. - Machine Learning A.I. Generative A.I. | 1 | 1 | 0 | 7 | |
Berkeley Lights Berkeley Lights is now part of Bruker Cellular Analysis Berkeley Lights is now part of Bruker Cellular Analysis biotech, single cell, micro-fluidics, cancer genomics, human oncology, life science, optics, molecular biology, and oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 1 | 9 | 43 | |
Paradromics Inc. Building a high data-rate brain computer interface (BCI) to provide technology solutions to unmet medical needs. CONNECTING THE HUMAN BRAIN What if we could restore or enhance function using the power of AI and advanced technology? Our direct data interface enables this connection. MISSION We are building a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. Our first clinical application will help severely motor-impaired people communicate, enabling social connection and restoring independence. ABOUT Paradromics was founded in 2015 by a team of engineers and neuroscientists, received early support from both NIH … Type: Startup Activities: biotech deeptech Technologies: Affective Computing | 5 | 1 | 4 | 78 | |
Aidence AI-powered clinical applications for the lung cancer pathway We believe that data is key to disease prevention, management, and treatment. Our team knows how to turn complex data science into practical and intuitive solutions that make physicians' work easier. Yet beyond state-of-the-art technology, we’re driven by the purpose of improving patients' lives. We made it our mission to provide AI that empowers healthcare and pharmaceutical professionals to deliver faster, more precise diagnostics and treatments. Our team of data scientists, software engineers, medical, regulatory, and business professionals cut through the hype around AI to build solutions tailored to the needs of … Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Deep Learning Data Analytics A.I. - Machine Learning | 7 | 0 | 5 | 27 | |
ScreenPoint Medical Transpara - Smart AI for early breast cancer detection. Confidence. Workflow. Results. Try the ScreenPoint Experience! ScreenPoint helps radiologists detect breast cancer confidently and faster. We develop and market image analysis and machine learning applications and services to improve early detection of breast cancer. Our flagship product - Transpara - has been evaluated in over 35+ peer-reviewed publications and has demonstrated consistent results, regardless of patient age, breast density, or ethnicity. Transpara uses the latest developments in machine learning such as Deep Learning and is trained with very large well curated databases of screening mammograms. Research and development at ScreenPoint … Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning A.I. - Deep Learning A.I. - Image Processing | 2 | 0 | 1 | 61 | |
Anametric, Inc. Quantum Photonics for Cybersecurity (formerly Bra-Ket Science) Anametric is developing new technologies and devices for chip scale quantum photonics, with a focus on cybersecurity. The company enjoys a close working relationship with Southern Methodist University (SMU) in Dallas, Texas. Together, we are commercializing innovative devices based on the SMU team’s advanced research along with Anametric’s deep experience in semiconductor design and cybersecurity. Type: Startup Activities: biotech deeptech Technologies: Semiconductors Cybersecurity | 0 | 0 | 0 | 8 | |
HiFiBiO Therapeutics HiFiBiO Therapeutics is a clinical stage biotherapeutics company mobilizing the human immune system to combat disease. HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS®, Drug Intelligence Science) to enhance the probability of success for immunotherapies. DIS® combines unique single-cell capabilities with AI/ML approaches using patient samples to discover novel targets, effective antibody drugs, and predictive biomarkers. With DIS®, HiFiBiO gains an unprecedented understanding of immune modulation in human diseases driving a robust clinical pipeline of transformative immunotherapies. Additionally, HiFiBiO has partnered with major multinational pharmaceutical and biotech companies applying its innovative DIS® approach. HiFiBiO … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 2 | 73 | |
Subtl Beauty A beauty brand designed for busy women, inspired by busy women. Subtl Beauty is an award-winning beauty company that was built to simplify the daily beauty routine of busy people on the go. Our mission is to revolutionize the beauty routine of modern women by delivering simplified yet effective makeup solutions cosmetics, beauty, retail, communications, and digital marketing Type: Startup Activities: martech cosmetics biotech deeptech | 1 | 0 | 0 | 15 | |
Tute Genomics Tute Genomics is a Utah-based company that is powering the world's genomic knowledge with a cloud-based solution for precision genome-guided medicine. Genomics is changing healthcare as we know it and Tute is helping to shape the future of medicine: unlocking the genome, personalizing treatment and powering discovery. Genomics, Genetics, Science-as-a-Service, and Biotech Type: Startup Activities: biotech deeptech Technologies: SaaS | 3 | 1 | 2 | 3 | |
Centiment (Acquired) Centiment is creating Brain Powered Advertising. Centiment is a neurodata driven AI company built to do good. For the first time in history, we have the ability to quantify, measure + understand human emotion. We are at the forefront of this shift and are helping pioneer a new age of unbiased, brain-powered marketing + advertising -- one that is emotionally-informed, purpose-driven and equal. Artifical Intelligence, Content, Advertising, machine learning, neuroscience, neurophysiology, programmatic advertising, and Marketing Type: Startup Activities: martech biotech deeptech Technologies: A.I. A.I. - Machine Learning | 2 | 1 | 0 | 1 | |
Stillwater MedTech Consulting Stillwater MedTech Consulting specializes in Quality, Regulatory and Operational needs of medical technology companies. We provide practical and responsive solutions to demands faced by industry. FDA, Medical Technology, Quality, Operations, Regulatory, Commercialization, Compliance, Clinical Trials, Reimbursement, Pharmaceutical Industry, Biotechnology, Medical Devices, Regulatory Affairs, Start-ups, Healthcare, Project Management, Product Launch, Regulatory Submissions, Product Development, Strategic Planning, and ISO Type: Startup Activities: deeptech healthtech biotech regtech | 0 | 0 | 0 | 3 | |
Inivata A leader in liquid biopsy transforming the lives of cancer patients and their families. Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications. Its lead product, InVisionFirstTM-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and its … Type: Startup Activities: biotech deeptech Technologies: SaaS | 2 | 0 | 0 | 44 | |
Locus Biosciences, Inc. Locus Biosciences, Inc. is a biotechnology company that develops precision, engineered bacteriophage products. Locus Biosciences is a clinical-stage biotechnology company developing engineered bacteriophage products to address critical unmet medical needs in bacterial infections and immunology. The LOCUS platform combines predictive artificial intelligence and automated robotics to deliver optimized precision phage therapies that specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unaffected. Locus has strong backing from partners, having signed contracts with BARDA and CARB-X. The company recently completed the open-label portion of a Phase 2 trial assessing LBP-EC01 for the treatment of uncomplicated … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 4 | 4 | 61 | |
Meta Company Meta Company Augmented Reality, Computer Vision, and Human Computer Interaction Type: Startup Activities: deeptech biotech Technologies: VR A.I. - Image Processing A.I. | 18 | 8 | 3 | 31 | |
Algonist Biotechnologies Targeting Chronic Pain Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain. Our mission is to develop drugs with similar potency to opioids but without leading to addiction. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Myllia Biotechnology Single-cell CRISPR screening - a powerful approach to fast-forward target identification and drug discovery Myllia Biotechnology combines CRISPR screening with single-cell RNA sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. We utilize the CRISPR screening workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next-generation CRISPR screens. Our powerful approach has broad applications in identifying novel drug targets or elucidating unknown mechanisms of actions (MoA) of drugs. Each screening project is customized to the specific needs of our clients and we perturb … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 24 | |
Calyxha Biotechnologies A new perspective on inflammation Calyxha is a private biotech company developing novel small molecule anti-inflammatory drugs. Drug discovery and development Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 2 | |
Lario Therapeutics Fighting neurological disorders with precision medicine. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
SamanTree Medical SA Bringing the unseen into focus for a cancer-free tomorrow SamanTree Medical proposes a breakthrough innovation for checking complete tumor removal during surgery: the Histolog® Scanner. This novel imaging modality is a direct support during cancer surgery to achieve the common goal of improving patient quality of life by decreasing rates of re-operation. The team is fully dedicated to bringing the Gold Standard in the operating room, enabling margin assessment, in real time, at the histological detail. SamanTree Medical SA was founded in December 2014 and is a spin-off of the EPFL (Ecole Polytechnique Fédérale de Lausanne). linktr.ee/SamanTree microscopy and digital … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 3 | 2 | 1 | 32 | |
HepaRegeniX GmbH Unlocking liver regeneration - delivering recovery HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases. Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 12 | |
Orlance Inc Delivering powdered, needle-free vaccines Orlance Inc is a company based out of Seattle, United States. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS | 0 | 0 | 0 | 7 | |
Leman Biotech Leman Biotech, a spin-off company of EPFL, aims at developing and commercializing new metabolic cancer immunotherapies Leman Biotech Co., Ltd. is a spin-off of EPFL co-founded by Prof. Li Tang (Head of Laboratory of Biomaterials for Immunoengineering). Leman Biotech aims at developing and commercializing new metabolic cancer immunotherapies. Recently, the start-up company closed a US$11 million angel financing round. The money raised will enable it to accelerate the preclinical studies of biomolecule and cell based therapies and prepare for entering clinical trials. The headquarter of the company is now in Shenzhen, a highly vibrant city with the highest number of … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Ethris Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform. Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners. Biotechnology, mRNA, LNPs, Vaccines, Therapeutics, Formulation, and Manufacturing Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 57 | |
Calico Biosystems Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
PartitionBio Ltd Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
NXI Therapeutics AG Creating Tomorrow's Immunotherapies NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
SERDA therapeutics Fast and effective therapeutic debridement of burn injuries and chronic ulcers. SERDA Therapeutics is a joint venture between Smith & Nephew and NLC, focused on developing innovative wound care solutions. The company is dedicated to bringing to market a proprietary, best-in-class, fast-acting therapeutic product for burn injuries and chronic ulcers. SERDA has completed a Phase 1 Safety and Tolerability study in July 2024. This study was a blinded, randomized study that examined the immediate and 21-day cumulative irritation potential of ascending enzyme concentrations in SN514 hydrogel. The results confirm best-in-class potential for SN514 as the protection of “periwound” skin is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Mango Materials Mango Materials' technology uses waste biogas (methane) to produce poly-hydroxyalkanoate (PHA) powder, a valuable biopolymer that is converted into a variety of eco-friendly, plastic products such as cosmetic packaging and a polyester replacement for textiles. Due to a rising preference for green products, demand for biodegradable and non petroleum-based plastics is growing rapidly. Our climate positive technology transforms greenhouse gas emissions into a biodegradable material for fashion and products, making a plastic substitute that is better than conventional plastics. bioplastics and methane Type: Startup Activities: biotech deeptech Technologies: New Materials | 8 | 3 | 4 | 37 | |
Orange Biotech Private Limited Established in 2010 Orange Biotech Private Limited is a prominent Indian Pharmaceutical company best known as Pharmaceutical Medicines exporter and supplier. The company is integrated in producing high quality pharma products focusing on unique, pioneering and qualitative range of Antibiotic, Injectable, Syrups and suspensions. Orange Biotech is a prominent WHO GMP certified ISO 9001:2008. The medications provided are acknowledged for quality, virtue and viability. To provide access to the best high quality healthcare products at affordable prices to everyone thereby improving and enhancing the quality of life. To become the most prominent pharmaceutical company with the highest level of operational … | 0 | 0 | 0 | 13 | |
UPSIDE Foods At UPSIDE Foods (formerly known as Memphis Meats), we're making your favorite food a force for good. Meat made from cells. We’re building the future you’re hungry for. *all meat shown is UPSIDE meat https://linktr.ee/upsidefoods Cultivated meat is new to many of us, and here at UPSIDE, we encourage education, learning, and fact-based debate. We ask that, in accordance with our values, you keep the conversation respectful to each other and to us. Thanks! cell culture, cultured meat, food science, food tech, meat, food, research and development, biology, process development, cell-based meat, and cultured meat Type: Startup Activities: agritech biotech deeptech foodtech manufacturing Technologies: Synthetic Biology | 16 | 6 | 4 | 254 | |
Stratégique Santé [Automatic translation follows] Health economics consulting and training Specialists in health market access strategies and health policies, we support you in all your issues related to the health or medico-social sector. Our consultants are also specialized in hospital management and public health. market access, HEOR, Health regularoty, medico-economic study, and PMSI Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 0 | 0 | 0 | 1 | |
Koï Coaching | Accompagnement des créateurs d'entreprise [Automatic translation follows] 💥Professional coaching for business creators and entrepreneurs💥 Koï Coaching is the only one to have combined professional coaching and financial expertise in order to provide complete support for business creators and entrepreneurs. Specialist in supporting business creators, entrepreneurs and managers, people are at the heart of our concerns. Our approach is flexible, comprehensive and resolutely action-oriented. The Koï Coaching Team is guided by three watchwords: > Pragmatic > Human > Multidisciplinary Do not hesitate to call us for any additional questions! Team Koï Coaching professional coaching, financial expertise, support for business creation, training, law, taxation, web marketing, … Type: SMB Activities: biotech deeptech edtech entrepreneurship fintech martech | 2 | 1 | 0 | 1 | |
Motryx Inc Quality control for specimen transport Simple and reliable validation of Pneumatic Tube Systems for blood sample integrity monitoring blood, pneumatic tube, transport, and labquality | 0 | 0 | 0 | 5 | |
Aker Arctic Technology Inc The Ice Technology Partner Aker Arctic Technology Inc (Aker Arctic) is an independent company specializing in the development, design, engineering and testing services for icebreakers and other ice-going vessels as well as offshore marine structures and ports. Our head office and ice laboratory is located in Helsinki, Finland. Our experienced, high qualified and innovative personnel are able to provide our customers specialised arctic know-how as well as new innovative and cost effective and reliable solutions for the arctic development. The company is running a special testing facility in Helsinki, the only privately owned ice model testing facility in the world. … | 2 | 1 | 2 | 60 | |
XL Precision Technologies Ltd Medical device component & sub-assembly contract manufacturer with production & development facilities in Europe & USA XL Precision Technologies specialise in the manufacturer of precision micro-components, complex tubular components and sub-assemblies for the medical device industry. Embedded in all of our development and production activities is our Quality Management System, where we are certified to ISO 13485. With sites in Stockton on Tees (UK) and West Chester (PA, USA), we are able serve our medical device customers in Europe and North America Our diverse machining capabilities include; - Laser Technology (cutting, welding & marking) - Electro-discharge machining (EDM) wire & … Type: SMB Activities: biotech deeptech healthtech manufacturing Technologies: 3D Printing | 1 | 0 | 1 | 66 | |
Arzeda The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 2 | 7 | 70 | |
Akron Bio Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to … Type: SMB Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 1 | 0 | 0 | 118 | |
MTInov [Automatic translation follows] Scale-up platform for the production of innovative therapy drugs based on human cells or tissues. The Biotherapy-Bioproduction integrator MTInov was born in 2020 from the association of the Cellular Therapy Unit and Tissue Bank of the CHRU of Nancy and the Bioprocesses Biomolecules research axis of the Reactions and Process Engineering Laboratory (CNRS, UL). This platform for the study, optimization, and scaling up of the production of cell-based biomedicines has expertise in cell culture in stirred bioreactors (online monitoring, intensification, modeling and design of bioreactors), as well as in the transfer to clinical grade in compliance with … Type: Public Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 2 | 0 | 2 |